Phytonadione 1 MG/0.5 ML SYR 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7ZTM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,352
Award facts
- Contract value 100% obligated
- $5,351.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $5,351.66 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 9, 2026, for the supply of Phytonadione 1 mg/0.5 mL syringes in 0.5 mL quantities. The contract is scheduled for completion by January 12, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order was awarded on a non-competitive basis as a child order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. Phytonadione, commonly known as vitamin K1, is a critical pharmaceutical used in military and federal healthcare systems for blood clotting management and prevention of hemorrhagic conditions in military personnel and veteran populations.
AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerSourceBergen), is a major pharmaceutical distributor serving as a prime vendor for federal medical procurement. The company maintains significant contract vehicles with the Defense Logistics Agency to supply comprehensive pharmaceutical products and medical supplies supporting military healthcare programs globally. AmerSourceBergen's federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements through open competition, with delivery orders ranging from small-value transactions to substantial orders exceeding $45,000, positioning the company as a critical supplier within the military's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F7ZTM?
SPE2DR26F7ZTM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F7ZTM worth?
The government has obligated $5,352 on SPE2DR26F7ZTM.
Is contract SPE2DR26F7ZTM an order under another contract?
Yes. SPE2DR26F7ZTM is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F7ZTM competed?
The extent of competition for SPE2DR26F7ZTM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award